Basics Apogee Therapeutics, Inc. IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $2.12B Activated in VL: True Average Daily Range Avg Daily Range: $1.11 | 2.89% Avg Daily Range (30 D): $0.90 | 2.38% Avg Daily Range (90 D): $1.08 | 3.01% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .5M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 876 Avg Inst. Trade: $2.74M Avg Inst. Trade (30 D): $2.68M Avg Inst. Trade (90 D): $2.47M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.68M Avg Closing Trade (30 D): $3.56M Avg Closing Trade (90 D): $3.52M Avg Closing Volume: 84.96K     News May 12, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: N/A May 1, 2025 @ 12:00 PM Apogee Therapeutics to Participate at the Bank of ... Source: N/A Mar 3, 2025 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Pha... Source: Apogee Therapeutics, Inc. Feb 3, 2025 @ 12:00 PM Apogee Therapeutics Announces First Patient Dosed ... Source: N/A Dec 2, 2024 @ 11:00 AM Apogee Therapeutics Highlights Progress and Best-i... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.95 $-.86 Diluted EPS $-.95 $-.86 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -55.34M $ -49.02M Operating Income / Loss $ $ -63.1M $ -58.69M Cost of Revenue $ $ $ Net Cash Flow $ $ -34.87M $ -188.52M PE Ratio     Splits Jan 08, 2008:   1:50